In fact, growth retardation appears to be significantly less severe and less frequent in patients with NSML and NS associated with SOS1 mutations compared to patients with NSSD associated with pathogenic variants in other RASopathy genes, such as patients with PTPN11, RAF1, and KRAS mutations (24). The gene discussed is PTPN11; the disease is RASopathy.